Trial Profile
Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms HERMES
- 02 Mar 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Aug 2011 New trial record